Covimectin 12 Tablet contains 12mg of Ivermectin, a powerful and widely used antiparasitic agent. It is prescribed for treating a variety of parasitic infections, including intestinal worms, scabies, lice, and strongyloidiasis. Additionally, Covimectin is frequently included in off-label viral treatment protocols, especially for immune support during seasonal or epidemic conditions.
This high-strength dosage is ideal for adults with higher body weight or as part of a multi-day immune protocol under medical guidance. Covimectin is one of the most trusted Ivermectin brands, known for fast action and consistent results.
Select options
This product has multiple variants. The options may be chosen on the product page
Crizalk 250 mg is an oral capsule formulation of crizotinib, a precision tyrosine kinase inhibitor developed for treatment of advanced or metastatic non‑small cell lung cancer (NSCLC) with specific genetic alterations. It inhibits ALK, ROS1, and MET‑exon 14 skipping mutations to halt cancer cell proliferation and improve survival outcomes in responsive patients.
Select options
This product has multiple variants. The options may be chosen on the product page
Cycloxan 50 mg is a chemotherapy tablet containing Cyclophosphamide, widely used in the treatment of various cancers, including leukemia, lymphoma, breast cancer, and ovarian cancer. It works by interfering with the growth of cancer cells, stopping them from multiplying. Cycloxan is taken orally and may be used as part of combination chemotherapy depending on the condition.
Select options
This product has multiple variants. The options may be chosen on the product page
Cytomid 250 mg contains flutamide, a non‑steroidal antiandrogen medication used in the treatment of prostate cancer. It works by blocking androgen receptors, thereby reducing the effect of testosterone on prostate tumor cells. Typically prescribed alongside surgical or medical castration methods, Cytomid helps to enhance cancer control in androgen-sensitive disease
Select options
This product has multiple variants. The options may be chosen on the product page
Cytotam 20 mg is an oral tablet containing tamoxifen, a widely used selective estrogen receptor modulator. It binds to estrogen receptors in breast tissue, preventing estrogen from stimulating the growth of hormone‑receptor positive tumors. Indications include adjuvant therapy for early breast cancer, treatment of metastatic disease, and risk reduction in high-risk women.
Select options
This product has multiple variants. The options may be chosen on the product page
Dexona 0.5 mg is a low‑dose oral tablet formulation containing dexamethasone, a potent systemic corticosteroid. It suppresses inflammation and modulates the immune response. Used in managing conditions such as asthma, arthritis, allergic reactions, dermatological disorders, and as adjunctive therapy in infections or cancer care—all under close physician guidance.
Select options
This product has multiple variants. The options may be chosen on the product page
Flonida Cream is a topical formulation containing 5% fluorouracil, a potent antimetabolite used in treating precancerous and superficial cancerous skin lesions. It works by inhibiting abnormal cell growth in damaged skin, making it ideal for treating actinic keratosis and superficial basal cell carcinoma. The cream offers localized, non-invasive therapy with minimal systemic absorption.
Select options
This product has multiple variants. The options may be chosen on the product page
Geftinat 250 mg is an oral tablet containing gefitinib, a first-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‑TKI). It is indicated for treating adult patients with advanced or metastatic non–small cell lung cancer (NSCLC) whose tumors have specific EGFR gene mutations. By inhibiting EGFR signaling, Geftinat helps block cancer cell proliferation and progression.
Select options
This product has multiple variants. The options may be chosen on the product page
Hydrea 500 mg is a prescription cytotoxic antimetabolite containing hydroxyurea. It is used in:
Chronic myeloid leukemia (CML) to reduce leukocyte counts and control disease
Head and neck cancers and other solid tumors as part of chemotherapy regimens
Sickle cell disease to reduce vaso-occlusive crises and red cell sickling
Hydroxyurea works by inhibiting ribonucleotide reductase, suppressing DNA synthesis in rapidly dividing cells. It may also promote fetal hemoglobin production, reducing sickling in sickle cell patients.
Select options
This product has multiple variants. The options may be chosen on the product page
IMAT 100 mg is an oral tablet formulation of imatinib, a selective tyrosine kinase inhibitor (TKI). It is indicated for adult patients with chronic myeloid leukemia (CML), Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), and c-KIT+ gastrointestinal stromal tumors (GIST). Imatinib targets BCR-ABL, c-KIT, and PDGFR tyrosine kinases, effectively blocking malignant cell growth and disease progression.
Select options
This product has multiple variants. The options may be chosen on the product page
IMAT 400 mg is a higher-strength oral tablet formulation of imatinib, a selective tyrosine kinase inhibitor (TKI). It’s indicated for patients with advanced or resistant chronic myeloid leukemia (CML), Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), and c-KIT+ gastrointestinal stromal tumors (GIST). By inhibiting BCR‑ABL, c‑KIT, and PDGFR tyrosine kinases, imatinib halts cancer cell growth and improves disease outcomes.
Select options
This product has multiple variants. The options may be chosen on the product page
